Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study.

Remote control (RC) of cardiac implantable electronic devices (CIEDs) has been tested as safe and effective in the magnetic resonance imaging space. We sought to evaluate RC applications of patients at home. RC of cardiac devices in patients' homes is feasible, safe, and effective, with consistent patient satisfaction.

Treatment of Cryptogenic Stroke Patients with Atrial Fibrillation Detected by Insertable Cardiac Monitors Reduces Recurrent Stroke Risk to Background Levels.

Atrial fibrillation (AF) is a known risk factor of ischemic stroke with a reported fivefold increase in incidence. However, it is not well established whether treatment with oral anticoagulation (OAC) in cryptogenic stroke patients with AF, detected by insertable cardiac monitors (ICMs), reduces the risk of recurrent stroke. We aimed to compare recurrent stroke rates between cryptogenic stroke patients who have AF detected by ICMs and thus started on OAC treatment and those without detected AF.

Subcutaneous implantable cardioverter defibrillator oversensing and shock delivery due to chest compressions during CPR.

We report the case of a patient who received both appropriate and inappropriate shocks from an entirely subcutaneous implantable defibrillator (S-ICD). The inappropriate shocks were due to oversensing of chest compressions in the setting of a profound postshock bradycardia. It is important to recognize that the therapy from the S-ICD can not only be withheld, as previously described, but can also be inappropriately delivered during chest compressions.